Rare diseases
Investigational molecules
Locations
Via Alessandro Manzoni 56, 20089 Rozzano, Italy
IRCCS Humanitas Research Hospital in Rozzano, Italy specialises in clinical trials of conditions such as Colitis ulcerative, Non-small cell lung cancer, Crohn's disease, Breast cancer, and other specialisations. This site conducts important research.
The medical center is at the forefront of nephrology research, focusing on innovative treatments for Idiopathic IgA nephropathy (IgAN). This condition, characterized by the deposition of IgA antibodies in the kidneys, can lead to significant renal impairment.
Through its research, the center aims to refine therapeutic strategies, minimizing the side effects associated with traditional treatments while enhancing patient outcomes. The integration of corticosteroids and SGLT2 inhibitors represents a significant advancement in managing proteinuria in IgAN patients.
Clinical trials currently enrolling participants at this site.
Study of maridebart cafraglutide for patients with heart failure with preserved or mildly reduced ejection fraction and obesity
ItalyA Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes
ItalyPhase 3 Randomized, Double‑Blind Study of Telitacicept versus Placebo for Efficacy and Safety in Adults with Active Primary Sjögren’s Disease
ItalyItalyPhase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA
ItalyStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
ItalyLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
ItalyA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
ItalyEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
ItalyLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
ItalyLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
ItalyA study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
ItalyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
